Learn how a biomarker-driven, diagnostics-enabled approach can facilitate the clinical, regulatory, and commercial success of drugs developed for neurodegenerative disorders. Learn more about Asuragen, a Bio-Techne brand and our Companion Diagnostics Services & Partnerships: https://www.bio-techne.com/diagnostics/companion-diagnostics